ReviewReviews in cardiovascular medicine2022

PCSK9 Inhibitor: Safe Alternative to Fill the Treatment Gap in Statin-Limited Conditions?

Ying Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.